1. Home
  2. HSAI vs EVO Comparison

HSAI vs EVO Comparison

Compare HSAI & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSAI
  • EVO
  • Stock Information
  • Founded
  • HSAI 2014
  • EVO 1993
  • Country
  • HSAI China
  • EVO Germany
  • Employees
  • HSAI N/A
  • EVO N/A
  • Industry
  • HSAI
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSAI
  • EVO Health Care
  • Exchange
  • HSAI Nasdaq
  • EVO Nasdaq
  • Market Cap
  • HSAI 1.8B
  • EVO 1.6B
  • IPO Year
  • HSAI 2023
  • EVO 2021
  • Fundamental
  • Price
  • HSAI $17.23
  • EVO $3.23
  • Analyst Decision
  • HSAI
  • EVO Buy
  • Analyst Count
  • HSAI 0
  • EVO 2
  • Target Price
  • HSAI N/A
  • EVO $5.90
  • AVG Volume (30 Days)
  • HSAI 6.6M
  • EVO 107.8K
  • Earning Date
  • HSAI 05-19-2025
  • EVO 05-21-2025
  • Dividend Yield
  • HSAI N/A
  • EVO N/A
  • EPS Growth
  • HSAI N/A
  • EVO N/A
  • EPS
  • HSAI N/A
  • EVO N/A
  • Revenue
  • HSAI $284,577,139.00
  • EVO $866,665,179.00
  • Revenue This Year
  • HSAI $68.02
  • EVO $3.70
  • Revenue Next Year
  • HSAI $34.07
  • EVO $10.32
  • P/E Ratio
  • HSAI N/A
  • EVO N/A
  • Revenue Growth
  • HSAI 10.66
  • EVO N/A
  • 52 Week Low
  • HSAI $3.52
  • EVO $2.85
  • 52 Week High
  • HSAI $24.18
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • HSAI 47.77
  • EVO 29.01
  • Support Level
  • HSAI $14.06
  • EVO $3.25
  • Resistance Level
  • HSAI $18.68
  • EVO $3.37
  • Average True Range (ATR)
  • HSAI 1.81
  • EVO 0.09
  • MACD
  • HSAI -0.46
  • EVO 0.00
  • Stochastic Oscillator
  • HSAI 35.43
  • EVO 13.44

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. The Group organized its operations into two segments: the LiDAR segment and the gas detection segment, out of which LiDAR segments derives maximum revenue. Geographically, the company operates into North America, Mainland China, Europe and Other regions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: